30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Kevin McLaughlin

Track

Insider profile

Currently holds positions in Acceleron Pharma Inc and Vericel Corp

Performance

Overall performance
0.6
Performance over holding periods
0.6
30 days 90 days 120 days
Average return -8% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Financial Officer, Senior Vice President, Treasurer Acceleron Pharma Inc Nov. 1, 2010 -
Independent Director Vericel Corp Jan. 1, 2017 -
Director Vericel Corp Jan. 7, 2015 - Jan. 1, 2017
Kevin McLaughlin's trades of Vericel Corp's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-15 2026-05-13
US Vericel Corp (VCEL)
PlS Planned sale
33,619 -17.5%
475.36
US$2,007,995 		33,619 -17.5% 475.36 US$2,007,995
2026-05-15 2026-05-13
US Vericel Corp (VCEL)
PlS Planned sale
38,065 -7.6%
46.79
US$713,707 		38,065 -7.6% 46.79 US$713,707
2026-05-13 2026-05-13
US Vericel Corp (VCEL)
PrS Proposed sale
66,800
426.58
US$266,392 		66,800 426.58 US$266,392
2026-02-13 2026-02-11
US Vericel Corp (VCEL)
PlS Planned sale
7,000 -31.7%
34.66
US$242,620 		7,000 -31.7% 34.66 US$242,620
2026-02-11 2026-02-11
US Vericel Corp (VCEL)
PrS Proposed sale
7,000
35.62
US$249,340 		7,000 35.62 US$249,340
2025-11-20 2025-11-19
US Invivyd Inc (IVVD)
B Purchase
50,000 +inf%
2.50
US$125,000 		50,000 +inf% 2.50 US$125,000
2025-11-12 2025-11-10
US Vericel Corp (VCEL)
PlS Planned sale
7,000 -31.7%
38.59
US$270,130 		7,000 -31.7% 38.59 US$270,130
2025-11-10 2025-11-10
US Vericel Corp (VCEL)
PrS Proposed sale
7,000
39.71
US$277,970 		7,000 39.71 US$277,970
2025-08-08 2025-08-06
US Vericel Corp (VCEL)
PlS Planned sale
7,000 -31.7%
35.92
US$251,440 		7,000 -31.7% 35.92 US$251,440
2025-08-06 2025-08-06
US Vericel Corp (VCEL)
PrS Proposed sale
7,000
35.92
US$251,457 		7,000 35.92 US$251,457
2025-05-09 2025-05-07
US Vericel Corp (VCEL)
PlS Planned sale
7,000 -31.7%
39.98
US$279,860 		7,000 -31.7% 39.98 US$279,860
2025-05-07 2025-05-07
US Vericel Corp (VCEL)
PrS Proposed sale
7,000
39.98
US$279,878 		7,000 39.98 US$279,878
2025-02-14 2025-02-12
US Vericel Corp (VCEL)
PlS Planned sale
1,000 -7.8%
55.43
US$55,430 		1,000 -7.8% 55.43 US$55,430
2025-02-14 2025-02-12
US Vericel Corp (VCEL)
PlS Planned sale
6,000 -33.5%
55.47
US$332,820 		6,000 -33.5% 55.47 US$332,820
2025-02-12 2025-02-12
US Vericel Corp (VCEL)
PrS Proposed sale
7,000
55.46
US$388,236 		7,000 55.46 US$388,236
2024-11-15 2024-11-13
US Vericel Corp (VCEL)
PlS Planned sale
7,000 -37.0%
55.54
US$388,780 		7,000 -37.0% 55.54 US$388,780
2024-11-13 2024-11-13
US Vericel Corp (VCEL)
PrS Proposed sale
7,000
55.54
US$388,802 		7,000 55.54 US$388,802
2024-08-09 2024-08-07
US Vericel Corp (VCEL)
PlS Planned sale
2,000 -14.4%
45.99
US$91,980 		2,000 -14.4% 45.99 US$91,980
2024-08-09 2024-08-07
US Vericel Corp (VCEL)
PlS Planned sale
5,000 -29.6%
45.92
US$229,600 		5,000 -29.6% 45.92 US$229,600
2024-08-07 2024-08-07
US Vericel Corp (VCEL)
PrS Proposed sale
7,000
45.94
US$321,596 		7,000 45.94 US$321,596
2021-01-06 2021-01-05
PlS Planned sale
4 -0.1%
123.50
US$494 		4 -0.1% 123.50 US$494
2021-01-06 2021-01-05
PlS Planned sale
296 -4.8%
122.85
US$36,364 		296 -4.8% 122.85 US$36,364
2021-01-06 2021-01-05
PlS Planned sale
499 -7.5%
121.89
US$60,823 		499 -7.5% 121.89 US$60,823
2021-01-06 2021-01-05
PlS Planned sale
700 -9.6%
120.43
US$84,301 		700 -9.6% 120.43 US$84,301
2021-01-06 2021-01-04
PlS Planned sale
300 -3.9%
124.45
US$37,335 		300 -3.9% 124.45 US$37,335
2021-01-06 2021-01-04
PlS Planned sale
667 -8.1%
124.47
US$83,021 		667 -8.1% 124.47 US$83,021
2021-01-06 2021-01-04
PlS Planned sale
600 -6.8%
123.49
US$74,094 		600 -6.8% 123.49 US$74,094
2021-01-06 2021-01-04
PlS Planned sale
200 -2.2%
125.49
US$25,098 		200 -2.2% 125.49 US$25,098
2021-01-06 2021-01-04
PlS Planned sale
713 -7.3%
124.28
US$88,612 		713 -7.3% 124.28 US$88,612
2021-01-06 2021-01-04
PlS Planned sale
800 -7.6%
123.54
US$98,832 		800 -7.6% 123.54 US$98,832
2020-12-15 2020-12-14
PlS Planned sale
42,528 -79.1%
130.14
US$5,534,594 		42,528 -79.1% 130.14 US$5,534,594
2020-12-11 2020-12-11
PlS Planned sale
3,100 -21.7%
125.00
US$387,500 		3,100 -21.7% 125.00 US$387,500
2020-12-11 2020-12-10
PlS Planned sale
500 -4.3%
125.12
US$62,560 		500 -4.3% 125.12 US$62,560
2020-12-11 2020-12-09
PlS Planned sale
3,872 -25.7%
125.03
US$484,116 		3,872 -25.7% 125.03 US$484,116
2020-04-10 2020-04-09
PlS Planned sale
17,226 -60.6%
88.19
US$1,519,161 		17,226 -60.6% 88.19 US$1,519,161
2020-04-10 2020-04-08
PlS Planned sale
3,703 -24.8%
87.50
US$324,012 		3,703 -24.8% 87.50 US$324,012
2020-04-10 2020-04-08
PlS Planned sale
5,921 -28.4%
86.79
US$513,884 		5,921 -28.4% 86.79 US$513,884
2020-04-10 2020-04-08
PlS Planned sale
15,410 -42.5%
85.80
US$1,322,178 		15,410 -42.5% 85.80 US$1,322,178
2020-04-10 2020-04-08
PlS Planned sale
3,803 -9.5%
84.89
US$322,837 		3,803 -9.5% 84.89 US$322,837
2020-04-10 2020-04-08
PlS Planned sale
5,037 -11.2%
83.68
US$421,496 		5,037 -11.2% 83.68 US$421,496
2020-04-10 2020-04-08
PlS Planned sale
2,900 -6.0%
82.83
US$240,207 		2,900 -6.0% 82.83 US$240,207
2020-01-03 2020-01-02
PlS Planned sale
1,566 -24.4%
52.52
US$82,246 		1,566 -24.4% 52.52 US$82,246
2020-01-03 2020-01-02
PlS Planned sale
2,300 -26.4%
52.49
US$120,727 		2,300 -26.4% 52.49 US$120,727
2020-01-03 2020-01-02
PlS Planned sale
1,713 -16.4%
52.51
US$89,950 		1,713 -16.4% 52.51 US$89,950
2019-09-10 2019-09-10
PlS Planned sale
173 -0.8%
45.75
US$7,915 		173 -0.8% 45.75 US$7,915